ImmunityBio has yet to finalize a registrational trial plan with the FDA in that papillary disease population, Soon-Shiong ...
After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. Jynneos, the only FDA-approved mpox ...
Research suggests booster doses may be necessary for monkeypox immunity ... In contrast, for previously vaccinated individuals, the median titer 28 days after a single dose of the MVA-BN vaccine ...
The Jynneos vaccine comes in two doses and is recommended for those who have been exposed to someone with mpox as well as ...
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people. Xylazine is an FDA-approved sedative and pain ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) ...
, opens new tab diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug ...
Healthy volunteers of all ages, races and genders are needed to continue vaccine development at the Saint Louis University Center for Vaccine Development. Participation in a vaccine study is voluntary ...